IP Library Granted Patent US 10,080,746
Granted Patent B2
US 10,080,746 · App. 15/533,865 · Granted Sep 25, 2018

Donepezil derivative and use thereof

Inventors: Fei Liu (Nanjing, CN); Cuixia Zhang (Nanjing, CN); Chenggang Lin (Nanjing, CN); Chunyan Zhou (Nanjing, CN); Pan Chen (Nanjing, CN); Wei Wang (Nanjing, CN); Lulu Wang (Nanjing, CN)
Assignee: NORATECH PHARMACEUTICALS, INC.
A61K31/445A61K31/045A61K31/235A61K47/44C07D211/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,080,746
App. No.
15/533,865
Granted
Sep 25, 2018
Kind
B2
Abstract

The present invention relates to a donepezil derivative of general formula (I) or a pharmaceutically acceptable salt thereof, wherein R in the formula is as disclosed herein; and a method for preparation thereof; and a composition comprising an effective amount of a compound of the general formula (I) or a pharmaceutically acceptable salt thereof. The present invention also relates to use of a compound of the general formula (I) or a pharmaceutically acceptable salt thereof in preparing a medicament for treating a disease resulted from an abnormality in acetylcholinesterase activity.

Claims (10)

1. A compound of formula (I):

or a pharmaceutically acceptable salt thereof, wherein R is C 7 alkyl group.

2. A method of treating dementia in a patient, comprising:

administering a compound according to claim 1 or a pharmaceutically acceptable salt thereof to said patient.

3. A pharmaceutical composition, comprising a compound according to claim 1 or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient.

4. The pharmaceutical composition of claim 3 , wherein the excipient is selected from one or more of castor oil, soybean oil, sesame oil, arachis oil, corn oil, cottonseed oil, or glycerides.

5. The pharmaceutical composition of claim 3 , further comprising a hydrotropic agent, the hydrotropic agent being selected from one or more of benzyl benzoate or alcohols.

6. The pharmaceutical composition according to claim 3 , further comprising a pain relief agent, the pain relief agent being selected from benzyl alcohol.

7. The pharmaceutical composition of claim 4 , wherein the excipient is castor oil.

8. The pharmaceutical composition of claim 5 , wherein the hydrotropic agent is benzyl benzoate.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2020
From: NORATECH PHARMACEUTICALS, INC.
To: NANJING NORATECH PHARMACEUTICALS CO., LTD
Reel/Frame 052176/0275 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 10, 2017
From: LIU, FEI; ZHANG, CUIXIA; LIN, CHENGGANG; ZHOU, CHUNYAN; CHEN, PAN; WANG, WEI; WANG, LULU
To: NORATECH PHARMACEUTICALS, INC.
Reel/Frame 042953/0820 →
Priority Claims (1)
CN 2014 1 0777222 · Dec 11, 2014 · national
Continuity (1)
Related Publication 20170319561A1 · Nov 9, 2017
Cited By (1)
US 12,433,887